Return
Company Page
VAXICAN
Founders
VAXICAN is a pre-clinical stage biotechnology spin-off from the University of Gdansk, developing a proprietary platform of enveloped virus-like particles (eVLPs) for therapeutic cancer vaccines. The platform is augmented by in-house machine learning and AI tools, with a lead HER2-targeting vaccine candidate advancing toward clinical readiness. Backed by the DeepTech Capital Consortium, VAXICAN is positioned at the forefront of next-generation cancer immunotherapy in Central Europe.
Company Founded in 2019
Healthtech & Biotech